FDA Drug Application (203322) for SUMATRIPTAN SUCCINATE by MYLAN LABS LTD

Back to FDA Applications sponsored by MYLAN LABS LTD

Application Number203322
Product Number001
FormINJECTABLE;SUBCUTANEOUS
DosageEQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameSUMATRIPTAN SUCCINATE
Active IngredientSUMATRIPTAN SUCCINATE



Back to FDA Applications sponsored by MYLAN LABS LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.